Besides, there is evidence that only by inhibiting the number of GFAP-positive glial cells is sufficient to induce depressive phase behavior in rats, classic anti-depression drugs such as fluoxetine can act as antidepressants to improve this pathological change and depressive-like behaviour (46). The gene discussed is GFAP; the disease is major depressive disorder.